| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/27/2008 | CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 08/26/2008 | US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 08/26/2008 | US7417145 Process for total synthesis of ecteinascidins and intermediates therefor |
| 08/26/2008 | US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 08/26/2008 | US7417042 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/21/2008 | WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity |
| 08/21/2008 | WO2008101139A1 Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolution |
| 08/21/2008 | WO2008100867A2 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases |
| 08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008098859A1 Hcv polymerase inhibitors |
| 08/21/2008 | WO2008098857A1 2-aminooxazolines as taar1 ligands |
| 08/21/2008 | WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 08/21/2008 | US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents |
| 08/21/2008 | US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives |
| 08/21/2008 | US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth |
| 08/21/2008 | US20080200501 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; |
| 08/21/2008 | US20080200476 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 08/21/2008 | US20080200469 Phthalazinone derivatives |
| 08/21/2008 | US20080200465 Antipathogenic benzamide compounds |
| 08/21/2008 | US20080200464 Use treating hepatocyte growth factor (HGF)-mediated diseases such as cancer; inhibitors of c-Met; e.g. 3-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenylamino)-N-phenylpyrazine-2-carboxamide |
| 08/21/2008 | US20080200462 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 08/21/2008 | US20080200461 Use as agricultural pesticide, fungicide, herbicide, also a pharmaceutical, for treating obesity, metabolic syndrome, atherosclerosis, cardiovascular disease and insulin resistance, diabetes, fungal infections; compounds are diamines or derivatives, with at least one tert-amine or quaternary ammonium |
| 08/21/2008 | US20080200460 Chemical Compounds |
| 08/21/2008 | US20080200445 Heterocyclic aspartyl protease inhibitors |
| 08/21/2008 | CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2676944A1 2-aminooxazolines as taar1 ligands |
| 08/21/2008 | CA2676906A1 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | CA2676715A1 Piperazine derivatives for treatment of ad and related conditions |
| 08/21/2008 | CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity |
| 08/21/2008 | CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/21/2008 | CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 08/20/2008 | EP1958948A1 Pyridazine compound and use thereof |
| 08/20/2008 | EP1958941A1 Oxazolidinones and their use as hypocholesterolemic agents |
| 08/20/2008 | EP1958940A1 Condensation reaction by metal catalyst |
| 08/20/2008 | EP1957485A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 08/20/2008 | EP1957480A1 Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof |
| 08/20/2008 | EP1957469A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| 08/20/2008 | EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 08/20/2008 | EP1957460A1 Bicyclic compounds with kinase inhibitory activity |
| 08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 08/20/2008 | EP1670770B1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1569647B1 Cyclohexyl compounds as ccr5 antagonists |
| 08/20/2008 | EP1567523B1 Indolyl derivatives |
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | CN101248067A Oxazolidinone derivatives and use thereof as antibiotics |
| 08/20/2008 | CN101248066A Non-steroidal progesterone receptor modulators |
| 08/20/2008 | CN101248065A Activator of peroxisome proliferator activated receptor delta |
| 08/20/2008 | CN101248064A Nitrocatechol derivatives as COMT inhibitors |
| 08/20/2008 | CN101248059A Substituted amide derivatives as protein kinase inhibitors |
| 08/20/2008 | CN101248046A Amide derivatives as kinase inhibitors |
| 08/20/2008 | CN101248044A Novel indole compounds |
| 08/20/2008 | CN100412074C Oxadiazole derivative containing carbazolyl and its electroluminescent device |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
| 08/19/2008 | US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414066 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
| 08/19/2008 | US7414063 e.g. 2-(2-bromo-4-fluoro-phenoxy)-ethyl]-[2-(isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester; serine/threonine kinase inhibitor; anticarcinogenic agent; solid tumor, leukemia |
| 08/19/2008 | US7414061 Aryl-isoxazol-4-yl-imidazole derivatives |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414055 Inhibitors of Akt activity |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 08/19/2008 | US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/14/2008 | WO2008098143A2 Antimicrobial compounds and methods of use |
| 08/14/2008 | WO2008098058A1 Pi 3-kinase inhibitors and methods of their use |
| 08/14/2008 | WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 08/14/2008 | WO2008097546A2 Compounds that inhibit cholinesterase |
| 08/14/2008 | WO2008097428A2 Compounds and compositions as modulators of gpr119 activity |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096820A1 Biphenyl derivative |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND |
| 08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
| 08/14/2008 | WO2008096094A1 Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators |
| 08/14/2008 | WO2008096093A1 Oxazole and thiazole derivatives and their uses |
| 08/14/2008 | WO2008095292A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008010984A3 Acridine activation of p53 and uses thereof |
| 08/14/2008 | US20080194826 4-aminopiperidines react with 2-furancarboxylic acid or 2-furoyl chloride; opiod antagonist |
| 08/14/2008 | US20080194815 Stable Liquid Formulations of Anionic Dyes |
| 08/14/2008 | US20080194629 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors |